HOME >> BIOLOGY >> NEWS
First production of a human protein with complex glycosylation in genetically modified yeast

LEBANON, NEW HAMPSHIRE (August 28, 2003): Yeasts and other fungi are reliable, cost-effective workhorses for the production of many industrial enzymes. However, biopharmaceutical companies currently manufacture few human therapeutic proteins using these organisms. The inability to correctly decorate human proteins with complex sugar molecules a process known as glycosylation has been the main obstacle that has prevented the use of fungal hosts for the expression of human therapeutics.

Today a team of scientists at GlycoFi, Inc. and Dartmouth College report the successful reengineering of the glycosylation pathway in the yeast Pichia pastoris. Published in the latest issue of Science, these results constitute the first fungal organism able to secrete a human glycoprotein with complex human glycosylation.

"The vast majority of therapeutic proteins are glycosylated and most require complex, human-like glycosylation to ensure therapeutic efficacy," said GlycoFi's Stephen Hamilton, Ph.D., lead author of the publication. "Mammalian cell lines can replicate human-like glycoprotein processing to a large extent, and so have traditionally been used to produce most protein therapeutics. However, mammalian cell culture systems have significant drawbacks including low protein yields, long fermentation times, production of a mixture of protein glycoforms, and ongoing viral contamination issues."

"Being able to produce human glycoproteins with homogenous N-glycan structures in a fungal host allows us to take advantage of the inherent commercial advantages of yeast and other fungal production systems," says Dr. Tillman Gerngross, GlycoFi chief scientific officer and associate professor of biochemical engineering at Dartmouth College. "Moreover, the ability to produce a homogeneous glycoprotein in yeast offers the biopharmaceutical industry a new tool for further understanding the structure-function relationships of glycoproteins and for potentially crea
'"/>


28-Aug-2003


Page: 1 2 3

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First International Scientific Conference on Childhood Leukaemia
5. First ever standards linking climate change, biodiversity and poverty seek global peer review
6. First genetic comparison of purebred domestic dogs produces surprises
7. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
8. First target for childhood malaria vaccine
9. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
10. First flavors form a lasting impression
11. STN International launches Derwent World Patents Index First View

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/7/2018)... ... September 06, 2018 , ... CTL Medical Corporation has ... commercial spine business, which includes its complete portfolio of spine-related patents and 510ks, ... from it. The deal will make CTL Medical the world’s exclusive provider of ...
(Date:8/31/2018)... ... August 30, 2018 , ... ... as a component of drug discovery programs. Longer-target engagement can result in improved ... low throughput, require expensive instrumentation, or require the alteration of the molecules involved. ...
(Date:8/29/2018)... ... August 28, 2018 , ... Johanna ... program that recognizes women of excellence in the field of intellectual property, and ... Johanna Dwyer Women in IP Award aims to encourage and support women in ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... ... August 28, 2018 , ... Cognition Corporation ®, a software company specializing ... NAVIGATE2018 . , Ryan Ward, Director of Engineering at Zimmer Biomet, has ... experienced engineer and manager with Zimmer Biomet for almost 15 years, Mr. Ward will ...
(Date:8/29/2018)... ... ... LabRoots , the leading provider of interactive virtual events for tech ... of a new gamification feature, allowing users to earn points by participating in the ... shirts. , Throughout each month, LabRoots users will earn points by building their profile, ...
(Date:8/26/2018)... Korea (PRWEB) , ... August 24, 2018 , ... ... paper on that stem cell-derived exosomes dramatically relieves atopic dermatitis and inhibits a ... , According to the paper, the symptoms of mice having severe atopic ...
(Date:8/21/2018)... ... August 21, 2018 , ... ... company specializing in medical device compliance and commercialization, has just released a ... , Written and presented by Dr. Mario Kossmann, ESEP at the 28th ...
Breaking Biology Technology:
Cached News: